Literature DB >> 9777025

Cardiac accumulation of citrate during brief myocardial ischaemia and reperfusion in the pig in vivo.

B Hassel1, A Ilebekk, T Tønnessen.   

Abstract

Citrate is a key intermediate in energy metabolism and an inhibitor of phosphofructokinase of the glycolytic pathway. During myocardial ischaemia glycolysis is the main source of cardiac ATP. The aim of the present study was to determine if myocardial ischaemia and reperfusion alter cardiac tissue levels of citrate. Open-chest, anaesthetized pigs were subjected to 10 min of regional myocardial ischaemia by occlusion of the left anterior descending coronary artery, with and without reperfusion, and to 10 min of global ischaemia by circulatory arrest. Citrate, amino acids, glucose and NH3 were measured in biopsies. Ischaemia, whether regional or global, caused a 60-70% increase in tissue levels of citrate. During 1 min of reperfusion following regional ischaemia the level of citrate increased 460%, to approximately 600 nmol g-1 wet weight. The level of glutamate decreased by 20-33% (corresponding to 1300-2200 nmol g-1 wet weight), indicating net consumption of this amino acid during ischaemia. The level of aspartate decreased 50% indicating conversion of aspartate to oxaloacetate for the synthesis of citrate. Theoretically, the accumulation of myocardial citrate during brief ischaemia and early reperfusion is large enough to significantly inhibit phosphofructokinase activity and could therefore affect the ability of the myocardium to increase the glycolytic rate in response to ischaemia. This could, however, be partly compensated by the metabolism of myocardial glutamate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777025     DOI: 10.1046/j.1365-201X.1998.0400e.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  6 in total

1.  Genetic analysis of iron citrate toxicity in yeast: implications for mammalian iron homeostasis.

Authors:  Opal S Chen; Shawn Hemenway; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-06       Impact factor: 11.205

2.  Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury.

Authors:  Gregory D Lewis; Ru Wei; Emerson Liu; Elaine Yang; Xu Shi; Maryann Martinovic; Laurie Farrell; Aarti Asnani; Marcoli Cyrille; Arvind Ramanathan; Oded Shaham; Gabriel Berriz; Patricia A Lowry; Igor F Palacios; Murat Taşan; Frederick P Roth; Jiangyong Min; Christian Baumgartner; Hasmik Keshishian; Terri Addona; Vamsi K Mootha; Anthony Rosenzweig; Steven A Carr; Michael A Fifer; Marc S Sabatine; Robert E Gerszten
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

3.  Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis.

Authors:  Lui G Forni; William McKinnon; Gwyn A Lord; David F Treacher; Jean-Marie R Peron; Philip J Hilton
Journal:  Crit Care       Date:  2005-09-13       Impact factor: 9.097

4.  Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia.

Authors:  Jiahua Guo; Yonghong Yong; Jiye Aa; Bei Cao; Runbin Sun; Xiaoyi Yu; Jingqiu Huang; Na Yang; Lulu Yan; Xinxin Li; Jing Cao; Nan Aa; Zhijian Yang; Xiangqing Kong; Liansheng Wang; Xuanxuan Zhu; Xiaohui Ma; Zhixin Guo; Shuiping Zhou; He Sun; Guangji Wang
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

5.  Citrate shows protective effects on cardiovascular and renal function in ischemia-induced acute kidney injury.

Authors:  Anja Bienholz; Jonas Reis; Pinar Sanli; Herbert de Groot; Frank Petrat; Hana Guberina; Benjamin Wilde; Oliver Witzke; Fuat H Saner; Andreas Kribben; Joel M Weinberg; Thorsten Feldkamp
Journal:  BMC Nephrol       Date:  2017-04-10       Impact factor: 2.388

6.  Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions.

Authors:  Dirk Bruegger; Gregor I Kemming; Matthias Jacob; Franz G Meisner; Christoph J Wojtczyk; Kristian B Packert; Peter E Keipert; N Simon Faithfull; Oliver P Habler; Bernhard F Becker; Markus Rehm
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.